Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04751929
Title Abemaciclib With or Without Atezolizumab for mCRPC
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements Yes
Sponsors Dana-Farber Cancer Institute
Indications

prostate adenocarcinoma

Therapies

Abemaciclib + Atezolizumab

Atezolizumab

Abemaciclib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST